GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (NSAIDS)
Clinical trial NCT00373685 · COMPLETED
Trial details
- NCT number
- NCT00373685
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2010-11-01
- Enrollment
- 8067
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.